Description

Etilefrine hydrochloride is an orally active α adrenergic agonist. Etilefrine hydrochloride is also an AMPK activator. Etilefrine hydrochloride can be used for the research of postural hypotension[1][2][3][4].-4°C (Powder, sealed storage, away from moisture)-Applications-Neuroscience-Neuromodulation-Formula-C10H16ClNO2-Citation–References-[1]Chi Xu, et al. Accurate Drug Repositioning through Non-tissue-Specific Core Signatures from Cancer Transcriptomes. Cell Rep. 2018 Oct 9;25(2):523-535.e5.|[2]R Yamazaki, et al. Effects of dihydroergotamine and Etilefrine on experimentally-induced postural hypotension in dogs. J Pharmacobiodyn. 1990 Sep;13(9):519-24.|[3]Bouaggad A, et al. The effect of oral etilefrine premedication on the incidence of hypotension during spinal anaesthesia. Eur J Anaesthesiol. 2000 Mar;17(3):177-81.|[4]Sylvain Tollis, et al. Chemical Interrogation of Nuclear Size Identifies Compounds with Cancer Cell Line-Specific Effects on Migration and Invasion. ACS Chem Biol. 2022 Feb 24.-CASNumber-943-17-9-MolecularWeight-217.69-Compound Purity-99.81-SMILES-OC(CNCC)C1=CC=CC(O)=C1.[H]Cl-Research_Area-Cardiovascular Disease-Solubility-DMSO : 100 mg/mL (ultrasonic)-Target-Adrenergic Receptor;AMPK-Isoform–Pathway-Epigenetics;GPCR/G Protein;Neuronal Signaling;PI3K/Akt/mTOR-MCE Product type-Biochemical Assay Reagents